Clinical Trial Update: Personalised Therapy for Metastatic ADPC Determined by Genetic Testing and Avatar Model Generation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on personalised therapy for metastatic adenocarcinoma determined by genetic testing and avatar model generation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma

Snippet

Sponsor: Hospital Universitario de Fuenlabrada | Conditions: Adenocarcinoma | Phase 2 | Status: UNKNOWN